Search Results 751-760 of 16995 for monoclonal antibody

1. Liver Cancer Clinical Trials - Mayo Clinic Research

   Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the ... The purpose of this study is to assess the efficacy and safety of tiragolumab, an ...

2. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   ... monoclonal antibody. History of autoimmune or immune mediated disease prior to enrollment. Subjects with hypothyroidism, diabetes, adrenal insufficiency or ...

3. Model Clarifies Immunotherapy for Multiple Myeloma - Mayo Clinic News Network

   The authors report that the mouse model helped evaluate different ways to combine standard chemotherapies with the antibody drugs. They evaluated toxicity ...

4. Transplant Medicine Clinical Trials - Medical Professionals

   The purpose of this study is to evaluate the utility of using anti-HLA antibody titer to measure the effectiveness of antibody lowering therapy (i.e. ...

5. 1 Mayo Family Medicine Rochester Publications 2021 Journal publications with Family Medicine clinicians. Family Medicine authors

   A Mobile Unit Overcomes the Challenges to Monoclonal Antibody Infusion for COVID-. 19 in Skilled Care Facilities. J Am Geriatr Soc 2021;69(4):868-873. 66 ...

6. A Phase 2 Study to See if Simtuzumab (GS-6624) is Safe and Works in Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   ... monoclonal antibody against LOXL2, in patients with IPF. Read More on PubMed. Additional contact information. Non-cancer trials contact form. Phone: 800-664 ...

7. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   History of severe hypersensitivity reaction to any monoclonal antibody. Prior malignancy active within the previous 3 years except for locally potentially ...

8. What is cancer immunotherapy? - Mayo Clinic News Network

   Bispecific antibodies. When the immune system detects cancer cells or other abnormal cells, it produces immune cells called antibodies to attack them.

9. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody and B-cell maturation antigen (BCMA)-directed therapy * Cohort D: Newly diagnosed multiple myeloma per IMWG with a history of 4 to 8 ...

10. A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303) - Mayo Clinic

    The purpose of this study is an open-label, dose-escalation, and safety expansion study of an anti-LILRB2 / PD-L1 bispecific antibody SPX- 303 in patients with ...